nasopharyng
swab
show
higher
posit
rate
oropharyng
swab
nasopharyng
swab
male
show
higher
posit
rate
femal
consist
nasopharyng
oropharyng
swab
poor
j
u
r
n
l
p
r
e
p
r
f
abstract
background
sinc
outbreak
coronaviru
diseas
wuhan
decemb
march
total
confirm
case
report
china
two
consecut
neg
rtpcr
test
result
respiratori
tract
specimen
requir
evalu
discharg
hospit
oropharyng
swab
common
sampl
howev
fals
neg
result
occur
late
stage
hospit
avoid
fals
neg
result
critic
essenti
review
medic
record
patient
receiv
test
specimen
simultan
compar
perform
nasopharyng
oropharyng
swab
patient
outpati
inpati
studi
median
age
year
women
higher
posit
rate
posit
teststot
test
observ
nasopharyng
swab
oropharyng
swab
especi
inpati
nasopharyng
swab
inpati
show
higher
posit
rate
outpati
nasopharyng
swab
male
show
higher
posit
rate
femal
especi
outpati
detect
specimen
slightli
increas
posit
rate
nasopharyng
swab
moreov
consist
nasopharyng
oropharyng
swab
poor
conclus
studi
suggest
nasopharyng
swab
may
suitabl
oropharyng
swab
stage
outbreak
decemb
coronaviru
diseas
occur
wuhan
china
spread
rapidli
becom
public
health
emerg
intern
concern
caus
sever
acut
respiratori
syndrom
coronaviru
infect
march
total
confirm
case
includ
wuhan
report
china
typic
symptom
includ
fever
dri
cough
fatigu
sputum
product
short
breath
peopl
suscept
includ
infant
children
human
human
transmiss
confirm
specif
drug
identifi
covid
current
wide
use
treatment
includ
antivir
treatment
arbidol
ribavirin
antibiot
corticosteroid
noninvas
invas
ventil
extracorpor
membran
critic
ill
patient
multipl
platform
develop
vaccin
pandem
speed
diagnosi
mainli
base
typic
symptom
bilater
involv
chest
radiograph
exposur
infect
patient
confirm
posit
nucleic
acid
test
numer
type
specimen
reversetranscriptasepolymerasechainreact
rtpcr
common
method
detect
target
n
e
gene
oropharyng
nasopharyng
swab
frequent
use
sampl
howev
neg
oropharyng
nasopharyng
swab
could
rule
patient
got
posit
type
specimen
includ
bronchoalveolar
lavag
fluid
j
u
r
n
l
p
r
e
p
r
f
balf
anal
swab
stool
urin
fals
neg
occur
posit
rtpcr
test
result
observ
patient
recov
evalu
differ
type
specimen
may
promot
posit
rate
posit
teststot
test
help
decis
discharg
hospit
sinc
februari
nucleic
acid
detect
use
nasopharyng
oropharyng
swab
perform
simultan
patient
hospit
review
medic
record
februari
march
compar
perform
nasopharyng
oropharyng
swab
detect
patient
receiv
test
specimen
simultan
diagnos
base
interim
guidanc
patient
show
like
symptom
fever
cough
fatigu
initi
screen
commun
hospit
fever
chest
xray
patient
fever
chest
xray
abnorm
would
admit
fever
clinic
outpati
design
hospit
get
rtpcr
test
chest
comput
tomographi
ct
scan
hospit
one
design
hospit
inpati
posit
result
rtpcr
test
hospit
inpati
hospit
transfer
hospit
hospit
one
design
hospit
sever
sever
patient
total
patient
collect
studi
includ
outpati
inpati
studi
approv
tongji
hospit
ethic
committe
nasopharyng
swab
collect
singl
nostril
accord
detail
video
previous
publish
studi
oropharyng
swab
collect
side
throat
accord
publish
video
chines
societi
laboratori
medicin
http
wwwcslmorgcncnnewsasp
nasopharyng
swab
oropharyng
swab
patient
taken
time
sent
rtpcr
test
simultan
data
includ
age
sex
rtpcr
result
extract
electron
medic
record
march
case
receiv
test
nasopharyng
oropharyng
swab
simultan
includ
studi
laboratori
confirm
perform
depart
laboratori
medicin
use
rtpcr
respiratori
tract
specimen
suggest
rtpcr
test
includ
nasopharyng
oropharyng
swab
sputum
bronchoalveolar
lavag
fluid
balf
oropharyng
swab
wide
use
begin
outbreak
specimen
collect
store
collect
tube
ml
viru
preserv
solut
rna
isol
tianlong
automat
nucleic
acid
extract
system
tianlong
xian
china
data
present
median
interquartil
iqr
rang
rang
categor
variabl
analyz
use
fisher
exact
test
correl
consist
analyz
use
mcnemar
test
kappa
coeffici
analys
done
spss
p
valu
consid
statist
signific
patient
outpati
inpati
studi
median
age
year
rang
year
women
posit
rate
total
outpati
inpati
vs
vs
vs
nasopharyng
oropharyng
swab
respect
tabl
posit
rate
nasopharyng
oropharyng
swab
outpati
decreas
sharpli
less
much
lower
earli
stage
outbreak
combin
posit
rate
calcul
either
result
nasopharyng
oropharyng
swab
posit
increas
total
outpati
inpati
respect
slightli
higher
nasopharyng
swab
j
u
r
n
l
p
r
e
p
r
f
respect
moreov
among
inpati
group
posit
rate
quit
differ
nasopharyng
oropharyng
swab
vs
infect
patient
must
hospit
evalu
discharg
hospit
base
result
nucleic
acid
detect
oropharyng
swab
may
caus
remark
fals
neg
result
lead
discharg
infect
patient
hospit
male
patient
show
significantli
higher
posit
rate
total
male
popul
total
femal
popul
male
outpati
femal
outpati
nasopharyng
oropharyng
swab
tabl
among
posit
result
oropharyng
swab
case
also
posit
nasopharyng
swab
account
remain
patient
includ
outpati
inpati
among
posit
result
nasopharyng
swab
case
neg
oropharyng
swab
account
consist
nasopharyng
oropharyng
swab
poor
tabl
two
consecut
neg
rtpcr
test
result
specimen
respiratori
tract
separ
least
day
requir
evalu
discharg
hospit
oropharyng
swab
sampl
still
common
sampl
howev
fals
neg
result
may
occur
late
j
u
r
n
l
p
r
e
p
r
f
stage
hospit
posit
rtpcr
test
result
found
recov
patient
two
week
discharg
live
found
stool
patient
studi
posit
rtpcr
test
result
show
quit
differ
nasopharyng
oropharyng
swab
nasopharyng
posit
case
neg
oropharyng
swab
indic
fals
neg
result
may
occur
use
oropharyng
swab
result
suggest
nasopharyng
swab
show
higher
posit
rate
oropharyng
swab
detect
oropharyng
swab
may
result
worryingli
high
fals
neg
rate
reduc
suscept
femal
observ
studi
consist
previou
studi
moreov
recent
metaanalysi
found
among
includ
chines
patient
male
account
femal
odd
conclus
nasopharyng
swab
show
higher
posit
rate
oropharyng
swab
studi
suggest
nasopharyng
swab
may
suitabl
oropharyng
swab
late
stage
outbreak
